##Beta blocker reduces lung inflammation in critical COVID-19 | Golden pharma
##Beta blocker reduces lung inflammation in critical COVID-19 patients##
As indicated in the journal of the American College of Cardiology, administration of IV metoprolol to COVID-19 patients with ARDS reduced lung inflammation associated with the disease
Metoprolol administration also resulted in better oxygenation and fewer days on mechanical ventilation and in the ICU
@Ethiomedicalconsultancy #Join#us#for#more Medical videos, Scientific tips, Medical books, Medical journals and Interesting case discussions
we provide medical consultaion... medicine and we discuss cases 📚📖📔... and we give Medical advice💉 to the public by the specific proffesionals👩⚕👨⚕. Contact admin: @DrMelsh ...